By Robert Preidt
HealthDay Reporter
MONDAY, Jan. 16, 2017 (HealthDay Information) -- Homosexual and bisexual males taking antiretroviral medicine to deal with HIV an infection could also be at elevated threat for syphilis, new analysis contends.
Based mostly on a overview of accessible proof, the investigators concluded that the medicine could enhance susceptibility to the bacterium that causes syphilis, though the research didn't show cause-and-effect.
The discovering would possibly clarify why new and repeat circumstances of syphilis in homosexual and bisexual males have risen sharply in comparison with different sexually transmitted infections over the previous decade, the researchers wrote.
The research group was led by Dr. Michael Rekart, from the College of British Columbia's Faculty of Inhabitants and Public Well being in Vancouver. The findings have been revealed within the Jan. 16 difficulty of the journal Sexually Transmitted Infections.
The authors of an editorial that accompanied the research mentioned the speculation is "intriguing" and "warrants cautious consideration." However the editorial additionally prompt that the rise in syphilis circumstances amongst homosexual and bisexual males could also be as a result of different components.
"We live in an period the place [antiretroviral therapy] is getting used to successfully deal with and forestall HIV an infection. To some extent this appears to have tempered the urgency to regulate different [sexually transmitted infections]. As historical past has proven many occasions over, that may be a expensive mistake," mentioned Susan Tuddenham, Maunank Shah and Khalil Ghanem, from Johns Hopkins College Faculty of Drugs in Baltimore.
"Over the previous 15 years, syphilis charges amongst [gay and bisexual men] have been rising unabated," Tuddenham and colleagues famous in a journal information launch.
"If additional investigations help a job for [antiretroviral therapy] in rising susceptibility to syphilis, this can present another reason why screening, prognosis and therapy of [sexually transmitted infections] in [gay and bisexual men] should be prioritized," the editorial concluded.
No comments:
Post a Comment